As the company’s stock soared, Xponential routinely told investors that it had never had a franchised studio close – a metric it used to signal the strength of its systems and the growth potential of its brands. But many franchisees had a different story to tell.
Analysis of select corporate transcripts through the lens of Joseph Harrington’s landmark paper, “Collusion in Plain Sight: Firms’ use of Public Announcements to Restrain Competition.”
Get an inside view of the biologics market, where rebate schemes appear to drive market share. You’ll learn how a complex system supports sluggish biosimilar uptake and other types of anticompetitive conduct.
The Capitol Forum has recently published a special report with an extract of reporting that has been done analyzing price, market share and generic formulary exclusion data to spot anticompetitive conduct.
